What is the half-life of Lixisenatide?

Lixisenatide has an approximate elimination half-life of 3 h.

How long does Lixisenatide stay in your system?

Roughly 97% of a dose has cleared after five half-lives — about ~15 h for Lixisenatide. That is the window that matters for washouts, bloodwork and surgery.

What are the risks of Lixisenatide?

Acute pancreatitis, including fatal cases, has been reported with GLP-1 receptor agonists Serious hypersensitivity reactions, including anaphylaxis Severe gastrointestinal reactions; dehydration can lead to acute kidney injury Acute gallbladder disease Never share a pen between patients

Lixisenatide

A GLP-1 receptor agonist, a synthetic analog of human GLP-1. Its current US label is the fixed combination with insulin glargine (Soliqua 100/33) for type 2 diabetes; the half-life here is lixisenatide’s, from that label.

Half-life: 3 h
Out of system: ~15 h
Route: Subcutaneous
Level: —

Class (GLP-1 receptor agonist), half-life and route from the FDA label: Soliqua 100/33 (insulin glargine and lixisenatide) injection (U.S. National Library of Medicine, DailyMed), checked 2026-09-26.

What Lixisenatide is used for

Adjunct to diet and exercise to improve blood-sugar control in adults with type 2 diabetes, as insulin glargine and lixisenatide (FDA label)

How it's typically used

Prescription medicine in the US, as the combination product. The prescriber sets the dose and schedule; the FDA label is cited on this page.

What to watch for

Acute pancreatitis, including fatal cases, has been reported with GLP-1 receptor agonists
Serious hypersensitivity reactions, including anaphylaxis
Severe gastrointestinal reactions; dehydration can lead to acute kidney injury
Acute gallbladder disease
Never share a pen between patients

Common questions

What is the half-life of Lixisenatide?: Lixisenatide has an approximate elimination half-life of 3 h.
How long does Lixisenatide stay in your system?: Roughly 97% of a dose has cleared after five half-lives — about ~15 h for Lixisenatide. That is the window that matters for washouts, bloodwork and surgery.
How is Lixisenatide taken?: Lixisenatide is typically administered by the subcutaneous route. Prescription medicine in the US, as the combination product. The prescriber sets the dose and schedule; the FDA label is cited on this page.
What are the risks of Lixisenatide?: Acute pancreatitis, including fatal cases, has been reported with GLP-1 receptor agonists Serious hypersensitivity reactions, including anaphylaxis Severe gastrointestinal reactions; dehydration can lead to acute kidney injury Acute gallbladder disease Never share a pen between patients

About GLP-1 & weight loss

What they are: Incretin analogues — GLP-1 and dual/triple agonists. They slow stomach emptying and act on appetite centres in the brain, so you eat less without white-knuckling it.
How they're run: One subcutaneous shot a week for most, on the same day each week. Doses climb in steps every four weeks; that slow titration is what keeps side effects tolerable.
What to watch: Nausea, constipation, and reflux are near-universal in the first month. Muscle is lost alongside fat unless you keep protein high and keep lifting. Tell any surgeon or anaesthetist you are on one.

Other glp-1 & weight loss

Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.